Although the expressions of CCD1, PCNA, and c-Myc proteins did not show significant downregulation after treatments in HCT-116 cells (KRAS MT CRC), they might be involved in alterations of the list of genes (Figure S2). The gene discussed is KRAS; the disease is colorectal carcinoma.